174 related articles for article (PubMed ID: 15290851)
1. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies.
Yang T; Hussain A; Paulson J; Abbruscato TJ; Ahsan F
Pharm Res; 2004 Jul; 21(7):1127-36. PubMed ID: 15290851
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary delivery of low molecular weight heparins.
Yang T; Mustafa F; Bai S; Ahsan F
Pharm Res; 2004 Nov; 21(11):2009-16. PubMed ID: 15587922
[TBL] [Abstract][Full Text] [Related]
3. Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.
Yang T; Arnold JJ; Ahsan F
J Drug Target; 2005 Jan; 13(1):29-38. PubMed ID: 15848952
[TBL] [Abstract][Full Text] [Related]
4. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
[TBL] [Abstract][Full Text] [Related]
5. Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats.
Yang T; Mustafa F; Ahsan F
J Pharm Pharmacol; 2004 Jan; 56(1):53-60. PubMed ID: 14980001
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.
Hussain A; Yang T; Zaghloul AA; Ahsan F
Pharm Res; 2003 Oct; 20(10):1551-7. PubMed ID: 14620506
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of UH and LMWH are similar with respect to antithrombin activity.
Morris TA; Jacobson A; Marsh JJ; Lane JR
Thromb Res; 2005; 115(1-2):45-51. PubMed ID: 15567452
[TBL] [Abstract][Full Text] [Related]
8. Nasal administration of low molecular weight heparin.
Arnold J; Ahsan F; Meezan E; Pillion DJ
J Pharm Sci; 2002 Jul; 91(7):1707-14. PubMed ID: 12115833
[TBL] [Abstract][Full Text] [Related]
9. Complexation of a poly-L-arginine with low molecular weight heparin enhances pulmonary absorption of the drug.
Rawat A; Yang T; Hussain A; Ahsan F
Pharm Res; 2008 Apr; 25(4):936-48. PubMed ID: 17955186
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
11. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin.
Bai S; Thomas C; Ahsan F
J Pharm Sci; 2007 Aug; 96(8):2090-106. PubMed ID: 17286291
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
[TBL] [Abstract][Full Text] [Related]
13. Chain length-dependent effects of alkylmaltosides on nasal absorption of enoxaparin.
Mustafa F; Yang T; Khan MA; Ahsan F
J Pharm Sci; 2004 Mar; 93(3):675-83. PubMed ID: 14762906
[TBL] [Abstract][Full Text] [Related]
14. [Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies].
Zhang YJ; Zhang Q; Yang J; Sun MJ; Wang XL; Chen MX; Wang Q; Jiang H
Yao Xue Xue Bao; 2007 Nov; 42(11):1195-200. PubMed ID: 18300478
[TBL] [Abstract][Full Text] [Related]
15. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
17. [Effect of self-microemulsifying system on cell tight junctions].
Sha XY; Fang XL
Yao Xue Xue Bao; 2006 Jan; 41(1):30-5. PubMed ID: 16683524
[TBL] [Abstract][Full Text] [Related]
18. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.
Brieger D; Dawes J
Thromb Haemost; 1997 Feb; 77(2):317-22. PubMed ID: 9157589
[TBL] [Abstract][Full Text] [Related]
19. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
